scorecardresearch
Business Today
Subscribe
Immersives UPSTART G20 Summit Corporate Petrol-Diesel Weather BT Bazaar
BT 100 BT Accenture PwC De-risking the Future BT-TR GCC Listing
Clear all
Search

COMPANIES

No Data Found

NEWS

No Data Found
Sign in Subscribe
events
Special
News
Markets
Stocks
Beta Drugs Ltd

Feedback
Beta Drugs Ltd

Beta Drugs Ltd (BETA) Share Price

  • Sector: Pharmaceuticals (Small Cap)
  • Volume: 4,400
Sep 14, 2023 00:00 IST-
  • NSE
  • Share
    • Whatsapp
    • Twitter
    • Facebook
₹1,025.70
₹25.70 (2.57%)
₹1002.05 Low
Today’s Performance
₹1060.1 High
₹600 Low
52 Week’s Performance
₹1111 High

STOCK ANALYSIS

STOCK PERFORMANCE

  • 1 Day 2.57%
  • 1 Week -1.65%
  • 1 Month 23.85%
  • 3 Months 28.21%
  • 6 Months 57.80%
  • 1 Year 31.68%
  • 3 Years 133.57%
  • 5 Years 60.94%

PEER COMPARISON

STOCK SUMMARY

  • Face Value (₹) 10.00
  • Beta 0.04
  • 52-Week Low (₹) 600.00
  • 52-Week High (₹) 1,111.00
  • Price-to-Book (X)* 8.02
  • Dividend Yield (%) 0.00
  • Price-to-Earnings (P/E) (X)* 32.10
  • Earnings Per Share (₹) 31.95
  • Sector Price Earning (X)* 33.20
  • Market Cap (₹ Cr.)* 986.09
  • * Vaues as of last close price

COMPETITORS

BT TV

thumb 39:53 Historic India-Middle East-Europe Corridor Puts China On Notice
THUMB 5:05 Delhi Tops In Terms Of Electric Buses After Arvind Kejriwal Govt Introduces 400 New Buses
thumb 4:42 The India-Middle East-Europe Corridor: A Counter To China's Belt & Road Initiative
THUMB 4:04 Putin Praises Modi’s ‘Make In India’, Cites Example To Russian Auto Industry
THUMB 9:44 Tata Motors' Electrifying Future: In Conversation With Shailesh Chandra On EV Expansion
View more

FINANCIAL ANALYSIS

Income Statement (₹ Cr.)
Balance Sheet (₹ Cr.)
Cash Flow (₹ Cr.)
Income Statement (₹ Cr.)
Balance Sheet (₹ Cr.)
Cash Flow (₹ Cr.)

RATIO ANALYSIS

Return on Equity (%)
Return on Assets (%)
Price-to-Earnings (P/E) (X)
Price to Book (x)
Return on Capital Employed (%)
Enterprise Value to EBITDA (X)
Net Profit Margin (%)
Gross Profit Margin (%)
EBITDA Margin (%)
Return on Equity (%)
Return on Assets (%)
Price-to-Earnings (P/E) (X)
Price to Book (x)
Return on Capital Employed (%)
Enterprise Value to EBITDA (X)
Net Profit Margin (%)
Gross Profit Margin (%)
EBITDA Margin (%)

SHAREHOLDING PATTERN

Summary (as on 30 sep 2022)

DEALS

No Data For Block Deal.

*Transaction of a minimum quantity of 500,000 shares or a minimum value of Rs 5 crore.
Jul 24, 2020 Sell
Beta Drugs Limited ,ADESH VENTURES LLP
  • Qty 108000
  • Average Price ₹95.52
Jul 24, 2020 PURCHASE
Beta Drugs Limited ,ONKAR SINGH
  • Qty 87200
  • Average Price ₹96.03
Sep 01, 2020 PURCHASE
Beta Drugs Limited ,BATRA VIJAY KUMAR
  • Qty 50400
  • Average Price ₹84.95
Jul 23, 2018 Sell
Beta Drugs Limited ,VORA FINANCIAL SERVICES PRIVATELIMITED
  • Qty 51200
  • Average Price ₹90.14
Oct 29, 2018 Sell
Beta Drugs Limited ,VALUEWORTH CAPITAL MANAGEMENT PVT LTD
  • Qty 52000
  • Average Price ₹70.06
Oct 29, 2018 PURCHASE
Beta Drugs Limited ,SACHIN KASERA
  • Qty 50400
  • Average Price ₹70.00
Nov 29, 2018 PURCHASE
Beta Drugs Limited ,BATRA VIJAY KUMAR
  • Qty 48800
  • Average Price ₹73.25
Oct 12, 2017 Sell
Beta Drugs Limited ,VALUEWORTH CAPITAL MANAGEMENT PVT LTD
  • Qty 144000
  • Average Price ₹102.00
Oct 12, 2017 Sell
Beta Drugs Limited ,SUNITA MEHTA
  • Qty 139200
  • Average Price ₹101.94
Oct 12, 2017 Sell
Beta Drugs Limited ,SUMAN P SABOO
  • Qty 64000
  • Average Price ₹102.00
*Transaction of a minimum quantity of 500,000 shares or a minimum value of Rs 5 crore.

FAQ’S

What was Beta Drugs Ltd share price previously?
Beta Drugs Ltd share price was up by 2.57% from the previous closing price of ₹1,000.00.
Who are peers of Beta Drugs Ltd?
The peers of Beta Drugs Ltd are Zydus Lifesciences Ltd, Alkem Laboratories Ltd, Divis Laboratories Ltd, Lupin Ltd, Cipla Ltd, Dr Reddys Laboratories Ltd, Biocon Ltd, Torrent Pharmaceuticals Ltd, Glaxosmithkline Pharmaceuticals Ltd, Syngene International Ltd, Aurobindo Pharma Ltd, Gland Pharma Ltd, Glenmark Pharmaceuticals Ltd, Sun Pharmaceuticals Industries Ltd.
Who is/are the promoter/promoters of Beta Drugs Ltd?
The promotor/promotors of Beta Drugs Ltd are Balwant Singh., Varun Batra, Rahul Batra, Manmohan Khanna, Rohit Parti, Rajni Brar, Seema Chopra, Ashutosh Shukla.
What has been 52-week high of Beta Drugs Ltd stocks?
The highest price of Beta Drugs Ltd stock is ₹1,111.00 in the last 52-week.
What is the share price of Beta Drugs Ltd (BETA) today on NSE?
As on Sep 14, 2023, Beta Drugs Ltd (BETA)’s share price on NSE is Rs 1025.7
What is the market cap of Beta Drugs Ltd (BETA?)
The current market capitalisation of Beta Drugs Ltd (BETA) is 986.09 crores
What is Beta Drugs Ltd Share symbol?
The symbol of Beta Drugs Ltd is BETA.
What is the PE ratio of Beta Drugs Ltd (BETA)?
The current PE ratio of Beta Drugs Ltd (BETA) is 32.10.
What is the PB ratio of Beta Drugs Ltd (BETA)?
The current PB ratio of Beta Drugs Ltd (BETA) is 8.02.
Today’s High & Low share prices of Beta Drugs Ltd (BETA) on NSE?
Today, the share price of Beta Drugs Ltd (BETA) on NSE touched a high of Rs 1060.1 and a low of Rs 1002.05
What price did Beta Drugs Ltd (BETA) shares open on the NSE today?
On NSE, the share price of Beta Drugs Ltd (BETA) opened at Rs 1015
What is the 52-week high of Beta Drugs Ltd (BETA)?
The 52-week high price of Beta Drugs Ltd (BETA) is Rs 1111
What is the 52-week low of Beta Drugs Ltd (BETA) ?
The 52-week low price of Beta Drugs Ltd (BETA) is Rs 600

ABOUT BETA DRUGS LTD

Beta Drugs Ltd, incorporated in the year 2005, has its registered office in Village Nandpur, Baddi, Himachal Pradesh, 174101, 91-1795-236196. The main industry in which Beta Drugs Ltd operates is Pharmaceuticals - Indian - Bulk Drugs.

Auditor/Auditors for Beta Drugs Ltd is/are Kalra Rai & Associates. In the main management, Rahul Batra is chairman and Rajni Brar is the company secretary for Beta Drugs Ltd.

  • BS Balwant Singh. Whole-time Director
  • VB Varun Batra Joint Managing Director
  • RB Rahul Batra Chairperson & M D
  • MK Manmohan Khanna Independent Director
  • RP Rohit Parti Independent Director
  • RB Rajni Brar Company Sec. & Compli. Officer
  • SC Seema Chopra Whole-time Director
  • AS Ashutosh Shukla Whole-time Director

Top Stories

Thank you! Your transaction has been completed successfully.
Sorry! Transaction failed. Please try again later.

DATA SOURCES: Corporate data, historical price & volume data published on this website have been sourced from CMOTS Internet Technologies Pvt. Ltd. BSE Quotes and NSE Quotes have been sourced from BSE Limited and NSE Data & Analytics Limited, respectively. All timestamps reflected here are in IST (Indian Standard Time). Stock Analysis section has been sourced from the mentioned partners.

DISCLAIMER: Any and all content on this website, including the tools/ analysis, is provided to you only for convenience and on an “as-is, as-available” basis without representation and warranties of any kind. The content and any output of such tools/ analysis is for informational purposes only and should not be relied upon or construed as investment advice or guarantee for any specific performance/ returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this website, you agree to the Terms of Service and Privacy Policy.